Aspirin usage connected with decrease in pancreatic cancer risk The use of aspirin at least once per month is connected with a significant decrease in pancreatic cancer risk, according to results of a big case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. Xiang-Lin Tan, Ph women viagra .D., M.D., a study fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative research are preliminary and don’t encourage widespread use of aspirin for this function. The results are not designed to suggest everyone should start taking aspirin once monthly to reduce their threat of pancreatic cancer, said Tan. People should discuss use of aspirin with their physicians because the drug carries some unwanted effects.
Aspirin cuts colon cancer risk for a few: Study Aspirin cuts the chance for colorectal cancers in people with a genetic condition that predisposes them to the deadly disease, a fresh study suggests. PICTURES: 10 myths about colon cancer What about everyone? The finding doesn’t apply to them, since aspirin could cause side effects including gastrointestinal bleeding. The 861 people in the British study experienced Lynch syndrome, a uncommon inherited disorder that puts them at risk for cancer tumor, including colon cancer. The condition accounts for an estimated 3 to 5 5 % of cancer of the colon cases. Previous analysis suggested that aspirin may help prevent colon cancer in that group. In the most recent study, people were assigned to take 600 mg of aspirin daily – about two regular-strength aspirin tablets – or dummy supplements.